Serial Number | 97773407 |
Word Mark | AVENCELL |
Filing Date | Monday, January 30, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, July 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 21, 2024 |
Goods and Services | Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease |
Goods and Services | Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 16, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 16, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | AvenCell Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02138 |
Party Name | AvenCell Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02138 |
Event Date | Event Description |
Thursday, February 2, 2023 | NEW APPLICATION ENTERED |
Thursday, February 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 26, 2023 | ASSIGNED TO EXAMINER |
Thursday, October 26, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, October 26, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, October 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 12, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, April 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, April 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, April 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, April 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 12, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Wednesday, May 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 21, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, May 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 16, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |